{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T07:31:50Z","timestamp":1789803110341,"version":"4.0.1"},"reference-count":118,"publisher":"Elsevier BV","issue":"4","content-domain":{"domain":["sfnmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Fetal and Neonatal Medicine"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/j.siny.2013.04.005","type":"journal-article","created":{"date-parts":[[2013,5,18]],"date-time":"2013-05-18T09:46:26Z","timestamp":1368870386000},"page":"216-223","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"title":["Newly emerging therapies for neonatal seizures"],"prefix":"10.1016","volume":"18","author":[{"given":"Ronit M.","family":"Pressler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Mangum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.siny.2013.04.005_bib1","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1542\/peds.70.2.165","article-title":"Neonatal seizures. I. Correlation of prenatal and perinatal events with outcomes","volume":"70","author":"Holden","year":"1982","journal-title":"Pediatrics"},{"key":"10.1016\/j.siny.2013.04.005_bib2","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1212\/WNL.55.4.506","article-title":"Electrographic seizures in neonates correlate with poor neurodevelopmental outcome","volume":"55","author":"McBride","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.siny.2013.04.005_bib3","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1212\/01.wnl.0000279335.85797.2c","article-title":"Long-term prognosis in children with neonatal seizures: a population-based study","volume":"69","author":"Ronen","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.siny.2013.04.005_bib4","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1212\/01.wnl.0000295674.34193.9e","article-title":"Neonatal status epilepticus vs recurrent neonatal seizures: clinical findings and outcome","volume":"69","author":"Pisani","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.siny.2013.04.005_bib5","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/pr.2012.66","article-title":"Neonatal seizures and postneonatal epilepsy: a 7-y follow-up study","volume":"72","author":"Pisani","year":"2012","journal-title":"Pediatr Res"},{"key":"10.1016\/j.siny.2013.04.005_bib6","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1203\/PDR.0b013e31822f24c7","article-title":"Risk factors for epilepsy in children with neonatal encephalopathy","volume":"70","author":"Glass","year":"2011","journal-title":"Pediatr Res"},{"key":"10.1016\/j.siny.2013.04.005_bib7","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1203\/00006450-200110000-00005","article-title":"Prolonged seizures exacerbate perinatal hypoxic\u2013ischemic brain damage","volume":"50","author":"Wirrell","year":"2001","journal-title":"Pediatr Res"},{"key":"10.1016\/j.siny.2013.04.005_bib8","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1212\/WNL.58.4.542","article-title":"Seizure-associated brain injury in term newborns with perinatal asphyxia","volume":"58","author":"Miller","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.siny.2013.04.005_bib9","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s40272-012-0005-1","article-title":"Clinical management of seizures in newborns: diagnosis and treatment","volume":"15","author":"van Rooij","year":"2013","journal-title":"Paediatr Drugs"},{"key":"10.1016\/j.siny.2013.04.005_bib10","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1177\/0883073808327832","article-title":"Controversies in neonatal seizure management","volume":"24","author":"Glass","year":"2009","journal-title":"J\u00a0Child Neurol"},{"key":"10.1016\/j.siny.2013.04.005_bib11","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.pediatrneurol.2008.03.003","article-title":"Neonatal seizures: dilemmas in workup and management","volume":"38","author":"Bassan","year":"2008","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.siny.2013.04.005_bib12","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1440-1754.2005.00638.x","article-title":"Drug treatment of neonatal seizures by neonatologists and paediatric neurologists","volume":"41","author":"Carmo","year":"2005","journal-title":"J\u00a0Paediatr Child Health"},{"key":"10.1016\/j.siny.2013.04.005_bib13","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1542\/peds.2007-3278","article-title":"Prophylactic phenobarbital administration after resolution of neonatal seizures: survey of current practice","volume":"122","author":"Guillet","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.siny.2013.04.005_bib14","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/j.1651-2227.2009.01659.x","article-title":"Approach to seizures in the neonatal period: a European perspective","volume":"99","author":"Vento","year":"2010","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.siny.2013.04.005_bib15","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.pediatrneurol.2008.04.008","article-title":"Off-label use of antiepileptic drugs for the treatment of neonatal seizures","volume":"39","author":"Silverstein","year":"2008","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.siny.2013.04.005_bib16","series-title":"Guidelines on neonatal seizures","author":"World Health Organization","year":"2011"},{"key":"10.1016\/j.siny.2013.04.005_bib17","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004218.pub2","article-title":"Anticonvulsants for neonates with seizures","volume":"4","author":"Booth","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.siny.2013.04.005_bib18","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1056\/NEJM199908123410704","article-title":"Phenobarbital compared with phenytoin for the treatment of neonatal seizures","volume":"341","author":"Painter","year":"1999","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.siny.2013.04.005_bib19","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1212\/01.WNL.0000106944.59990.E6","article-title":"Second-line anticonvulsant treatment of neonatal seizures: a video-EEG monitoring study","volume":"62","author":"Boylan","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.siny.2013.04.005_bib20","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2165\/00003495-200868010-00002","article-title":"Antiepileptic drug development in children: considerations for a revisited strategy","volume":"68","author":"Chiron","year":"2008","journal-title":"Drugs"},{"issue":"7","key":"10.1016\/j.siny.2013.04.005_bib21","doi-asserted-by":"crossref","DOI":"10.3310\/hta10070","article-title":"The clinical effectiveness and cost-effectiveness of newer drugs for children with epilepsy. A systematic review","volume":"10","author":"Connock","year":"2006","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.siny.2013.04.005_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.eplepsyres.2010.07.004","article-title":"RCTs with new antiepileptic drugs in children: a systematic review of monotherapy studies and their methodology","volume":"91","author":"Weijenberg","year":"2010","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.siny.2013.04.005_bib23","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.tins.2008.09.002","article-title":"Neuro-archaeology: pre-symptomatic architecture and signature of neurological disorders","volume":"31","author":"Ben-Ari","year":"2008","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.siny.2013.04.005_bib24","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.clp.2009.08.001","article-title":"Neonatal seizures: an update on mechanisms and management","volume":"36","author":"Jensen","year":"2009","journal-title":"Clin Perinatol"},{"key":"10.1016\/j.siny.2013.04.005_bib25","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/s00431-008-0671-8","article-title":"EU initiatives for research involving children","volume":"167","author":"Donnelly","year":"2008","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.siny.2013.04.005_bib26","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/BF00561479","article-title":"Pharmacokinetics of diuretics and methylxanthines in the baby","volume":"18","author":"Aranda","year":"1980","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.siny.2013.04.005_bib27","doi-asserted-by":"crossref","first-page":"426","DOI":"10.2165\/00003495-198428050-00003","article-title":"Bumetanide: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic use","volume":"28","author":"Ward","year":"1984","journal-title":"Drugs"},{"key":"10.1016\/j.siny.2013.04.005_bib28","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/S1474-4422(06)70626-3","article-title":"Effects of seizures on developmental processes in the immature brain","volume":"5","author":"Ben Ari","year":"2006","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.siny.2013.04.005_bib29","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1152\/physrev.00017.2006","article-title":"a pioneer transmitter that excites immature neurons and generates primitive oscillations","volume":"87","author":"Ben-Ari","year":"2007","journal-title":"Physiol Rev"},{"key":"10.1016\/j.siny.2013.04.005_bib30","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/nm1301","article-title":"NKCC1 transporter facilitates seizures in the developing brain","volume":"11","author":"Dzhala","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.siny.2013.04.005_bib31","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.neuron.2009.08.022","article-title":"Differences in cortical versus subcortical GABAergic signaling: a candidate mechanism of electroclinical uncoupling of neonatal seizures","volume":"63","author":"Glykys","year":"2009","journal-title":"Neuron"},{"key":"10.1016\/j.siny.2013.04.005_bib32","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/ana.21229","article-title":"Bumetanide enhances phenobarbital efficacy in a neonatal seizure model","volume":"63","author":"Dzhala","year":"2008","journal-title":"Ann Neurol"},{"issue":"Pt 3","key":"10.1016\/j.siny.2013.04.005_bib33","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1113\/jphysiol.2006.107086","article-title":"The cation-chloride cotransporter NKCC1 promotes sharp waves in the neonatal rat hippocampus","volume":"573","author":"Sipil\u00e4","year":"2006","journal-title":"J\u00a0Physiol"},{"key":"10.1016\/j.siny.2013.04.005_bib34","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1152\/jn.90402.2008","article-title":"Excitatory GABA in rodent developing neocortex in\u00a0vitro","volume":"100","author":"Rheims","year":"2008","journal-title":"J\u00a0Neurophysiol"},{"key":"10.1016\/j.siny.2013.04.005_bib35","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1177\/1073858412438697","article-title":"The GABA excitatory\/inhibitory shift in brain maturation and neurological disorders","volume":"18","author":"Ben-Ari","year":"2012","journal-title":"Neuroscientist"},{"key":"10.1016\/j.siny.2013.04.005_bib36","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/pr.2012.7","article-title":"Bumetanide augments the neuroprotective efficacy of phenobarbital plus hypothermia in a neonatal hypoxia\u2013ischemia model","volume":"71","author":"Liu","year":"2012","journal-title":"Pediatr Res"},{"key":"10.1016\/j.siny.2013.04.005_bib37","doi-asserted-by":"crossref","first-page":"e57148","DOI":"10.1371\/journal.pone.0057148","article-title":"Bumetanide enhances phenobarbital efficacy in a rat model of hypoxic neonatal seizures","volume":"8","author":"Cleary","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.siny.2013.04.005_bib38","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1177\/009127009803801102","article-title":"Pharmacokinetics and pharmacodynamics of bumetanide in critically ill pediatric patients","volume":"38","author":"Marshall","year":"1998","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.siny.2013.04.005_bib39","doi-asserted-by":"crossref","first-page":"233","DOI":"10.2165\/11596620-000000000-00000","article-title":"Clinical pharmacology of the loop diuretics furosemide and bumetanide in neonates and infants","volume":"14","author":"Pacifici","year":"2012","journal-title":"Paediatr Drugs"},{"key":"10.1016\/j.siny.2013.04.005_bib40","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0009-9236(96)90197-6","article-title":"Pharmacokinetics of bumetanide in critically ill infants","volume":"60","author":"Sullivan","year":"1996","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.siny.2013.04.005_bib41","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/S0009-9236(96)90198-8","article-title":"Analysis of the variability in the pharmacokinetics and pharmacodynamics of bumetanide in critically ill infants","volume":"60","author":"Sullivan","year":"1996","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.siny.2013.04.005_bib42","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1159\/000244492","article-title":"The pharmacokinetics of bumetanide in the newborn infant","volume":"72","author":"Lopez-Samblas","year":"1997","journal-title":"Biol Neonate"},{"key":"10.1016\/j.siny.2013.04.005_bib43","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1542\/peds.2005-1707","article-title":"Reported medication use in the neonatal intensive care unit: data from a large national data set","volume":"117","author":"Clark","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.siny.2013.04.005_bib44","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/j.1552-4604.1982.tb02648.x","article-title":"Protein binding and bilirubin displacing properties of bumetanide and furosemide","volume":"22","author":"Turmen","year":"1982","journal-title":"Clin Pharmacol"},{"key":"10.1016\/j.siny.2013.04.005_bib45","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1159\/000457701","article-title":"The bilirubin-displacing capacity of bumetanide in critically ill babies","volume":"11","author":"Walker","year":"1988","journal-title":"Dev Pharmacol Ther"},{"key":"10.1016\/j.siny.2013.04.005_bib46","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/0165-0173(94)00006-B","article-title":"Ototoxicity in developing mammals","volume":"20","author":"Henley","year":"1995","journal-title":"Brain Res Rev"},{"key":"10.1016\/j.siny.2013.04.005_bib47","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1002\/j.1552-4604.1981.tb05675.x","article-title":"Comparative ototoxicity of bumetanide and furosemide when used in combination with kanamycin","volume":"21","author":"Brummett","year":"1981","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.siny.2013.04.005_bib48","doi-asserted-by":"crossref","first-page":"428","DOI":"10.3109\/00016488409107584","article-title":"Age-dependent changes in susceptibility to ototoxic hearing loss","volume":"98","author":"Prieve","year":"1984","journal-title":"Acta Otolaryngol"},{"key":"10.1016\/j.siny.2013.04.005_bib49","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/j.1552-4604.1981.tb05673.x","article-title":"Comparison of adverse reactions to bumetanide and furosemide","volume":"21","author":"Tuzel","year":"1981","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.siny.2013.04.005_bib50","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/S0009-9236(96)90199-X","article-title":"Dose-ranging evaluation of bumetanide pharmacodynamics in critically ill infants","volume":"60","author":"Sullivan","year":"1996","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.siny.2013.04.005_bib51","doi-asserted-by":"crossref","first-page":"e722","DOI":"10.1542\/peds.2008-0269","article-title":"Free radical injury and blood\u2013brain barrier permeability in hypoxic\u2013ischemic encephalopathy","volume":"122","author":"Kumar","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.siny.2013.04.005_bib52","doi-asserted-by":"crossref","first-page":"5547","DOI":"10.1523\/JNEUROSCI.5599-07.2008","article-title":"GABA regulates excitatory synapse formation in the neocortex via NMDA receptor activation","volume":"28","author":"Wang","year":"2008","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.siny.2013.04.005_bib53","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1093\/cercor\/bhq124","article-title":"Blocking early GABA depolarization with bumetanide results in permanent alterations in cortical circuits and sensorimotor gating deficits","volume":"21","author":"Wang","year":"2011","journal-title":"Cereb Cortex"},{"key":"10.1016\/j.siny.2013.04.005_bib54","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1177\/0883073809333526","article-title":"Decreased seizure activity in a human neonate treated with bumetanide, an inhibitor of the NA+-K+-2Cl\u2013 cotransporter NKCC1","volume":"24","author":"Kahle","year":"2009","journal-title":"J\u00a0Child Neurol"},{"key":"10.1016\/j.siny.2013.04.005_bib55","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1212\/01.wnl.0000252941.50833.4a","article-title":"Comparison of levetiracetam and controlled-release carbamazepine in newly diagnosed epilepsy","volume":"68","author":"Brodie","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.siny.2013.04.005_bib56","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1111\/j.1528-1157.2000.tb04605.x","article-title":"Efficacy and tolerability of levetiracetam 3000 mg\/d in patients with refractory partial seizures: a multicenter, double-blind, responder-selected study evaluating monotherapy. European Levetiracetam Study Group","volume":"41","author":"Ben-Menachem","year":"2000","journal-title":"Epilepsia"},{"key":"10.1016\/j.siny.2013.04.005_bib57","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1212\/01.wnl.0000297512.18364.40","article-title":"Levetiracetam for the treatment of idiopathic generalized epilepsy with myoclonic seizures","volume":"70","author":"Noachtar","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.siny.2013.04.005_bib58","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1212\/01.wnl.0000268699.34614.d3","article-title":"Placebo-controlled study of levetiracetam in idiopathic generalized epilepsy","volume":"69","author":"Berkovic","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.siny.2013.04.005_bib59","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1212\/01.wnl.0000217916.00225.3a","article-title":"Double-blind placebo-controlled trial of adjunctive levetiracetam in pediatric partial seizures","volume":"66","author":"Glauser","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.siny.2013.04.005_bib60","doi-asserted-by":"crossref","first-page":"9861","DOI":"10.1073\/pnas.0308208101","article-title":"The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam","volume":"101","author":"Lynch","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.siny.2013.04.005_bib61","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1006\/phrs.2000.0689","article-title":"Inhibition of neuronal hypersynchrony in\u00a0vitro differentiates levetiracetam from classical antiepileptic drugs","volume":"42","author":"Margineanu","year":"2000","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.siny.2013.04.005_bib62","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1124\/jpet.107.126250","article-title":"Antiepileptic drug-induced neuronal cell death in the immature brain: effects of carbamazepine, topiramate, and levetiracetam as monotherapy versus polytherapy","volume":"323","author":"Kim","year":"2007","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.siny.2013.04.005_bib63","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/ana.23600","article-title":"Neonatal exposure to antiepileptic drugs disrupts striatal synaptic development","volume":"72","author":"Forcelli","year":"2012","journal-title":"Ann Neurol"},{"key":"10.1016\/j.siny.2013.04.005_bib64","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.1529-8027.2011.00355.x","article-title":"Levetiracetam exhibits protective properties on rat Schwann cells in\u00a0vitro","volume":"16","author":"Stettner","year":"2011","journal-title":"Peripher Nerv Syst"},{"key":"10.1016\/j.siny.2013.04.005_bib65","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0014-2999(98)00410-5","article-title":"Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy","volume":"353","author":"Klitgaard","year":"1998","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.siny.2013.04.005_bib66","doi-asserted-by":"crossref","first-page":"707","DOI":"10.2165\/00003088-200443110-00002","article-title":"Clinical pharmacokinetics of levetiracetam","volume":"43","author":"Patsalos","year":"2004","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.siny.2013.04.005_bib67","first-page":"31","article-title":"A\u00a0systematic review of the pharmacokinetics of antiepileptic drugs in neonates with refractory seizures","volume":"17","author":"Tulloch","year":"2012","journal-title":"J\u00a0Pediatr Pharmacol Ther"},{"key":"10.1016\/j.siny.2013.04.005_bib68","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jpeds.2011.03.057","article-title":"Pharmacokinetics of levetiracetam in neonates with seizures","volume":"159","author":"Merhar","year":"2011","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.siny.2013.04.005_bib69","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/pr.2012.51","article-title":"A\u00a0seven-day study of the pharmacokinetics of intravenous levetiracetam in neonates: marked changes in pharmacokinetics occur during the first week of life","volume":"72","author":"Sharpe","year":"2012","journal-title":"Pediatr Res"},{"key":"10.1016\/j.siny.2013.04.005_bib70","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1177\/0883073807299973","article-title":"Levetiracetam for the treatment of neonatal seizures","volume":"22","author":"Shoemaker","year":"2007","journal-title":"J\u00a0Child Neurol"},{"key":"10.1016\/j.siny.2013.04.005_bib71","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1177\/0883073809348795","article-title":"Intravenous levetiracetam in children with seizures: a prospective safety study","volume":"25","author":"Ng","year":"2010","journal-title":"J\u00a0Child Neurol"},{"key":"10.1016\/j.siny.2013.04.005_bib72","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.seizure.2010.01.003","article-title":"Levetiracetam in the treatment of neonatal seizures: a pilot study","volume":"19","author":"F\u00fcrwentsches","year":"2010","journal-title":"Seizure"},{"key":"10.1016\/j.siny.2013.04.005_bib73","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejpn.2010.10.003","article-title":"Levetiracetam: safety and efficacy in neonatal seizures","volume":"15","author":"Ramantani","year":"2011","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.siny.2013.04.005_bib74","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.pediatrneurol.2010.11.005","article-title":"Use of intravenous levetiracetam for management of acute seizures in neonates","volume":"44","author":"Khan","year":"2011","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.siny.2013.04.005_bib75","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1177\/0883073810384263","article-title":"Levetiracetam for treatment of neonatal seizures","volume":"26","author":"Abend","year":"2011","journal-title":"J\u00a0Child Neurol"},{"key":"10.1016\/j.siny.2013.04.005_bib76","article-title":"The effect of levetiracetam on neuronal apoptosis in neonatal rat model of hypoxic ischemic brain injury","author":"Kilicdag","year":"2012","journal-title":"Early Hum Dev"},{"key":"10.1016\/j.siny.2013.04.005_bib77","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1517\/14656566.7.6.811","article-title":"Topiramate and its clinical applications in epilepsy","volume":"7","author":"Guerrini","year":"2006","journal-title":"Expert Opin Pharmacother"},{"issue":"Suppl. 1","key":"10.1016\/j.siny.2013.04.005_bib78","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1111\/j.1528-1157.2000.tb02163.x","article-title":"An overview of the preclinical aspects of topiramate: pharmacology, pharmacokinetics, and mechanism of action","volume":"41","author":"Shank","year":"2000","journal-title":"Epilepsia"},{"key":"10.1016\/j.siny.2013.04.005_bib79","doi-asserted-by":"crossref","first-page":"7979","DOI":"10.1523\/JNEUROSCI.1734-08.2008","article-title":"Early alterations of AMPA receptors mediate synaptic potentiation induced by neonatal seizures","volume":"28","author":"Rakhade","year":"2008","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.siny.2013.04.005_bib80","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/ana.1122","article-title":"Topiramate blocks perinatal hypoxia-induced seizures in rat pups","volume":"50","author":"Koh","year":"2001","journal-title":"Ann Neurol"},{"key":"10.1016\/j.siny.2013.04.005_bib81","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0920-1211(02)00157-2","article-title":"Effect of topiramate following recurrent and prolonged seizures during early development","volume":"51","author":"Cha","year":"2002","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.siny.2013.04.005_bib82","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.neuropharm.2004.02.010","article-title":"Topiramate selectively protects against seizures induced by ATPA, a GluR5 kainate receptor agonist","volume":"46","author":"Kaminski","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.siny.2013.04.005_bib83","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/j.0013-9580.2004.69103.x","article-title":"NBQX or topiramate treatment after perinatal hypoxia-induced seizures prevents later increases in seizure-induced neuronal injury","volume":"45","author":"Koh","year":"2004","journal-title":"Epilepsia"},{"key":"10.1016\/j.siny.2013.04.005_bib84","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1111\/j.0013-9580.2004.13504.x","article-title":"The mechanism of neuroprotection by topiramate in an animal model of epilepsy","volume":"45","author":"Kudin","year":"2004","journal-title":"Epilepsia"},{"key":"10.1016\/j.siny.2013.04.005_bib85","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1161\/01.STR.0000128029.50221.fa","article-title":"Topiramate extends the therapeutic window for hypothermia-mediated neuroprotection after stroke in neonatal rats","volume":"35","author":"Liu","year":"2004","journal-title":"Stroke"},{"key":"10.1016\/j.siny.2013.04.005_bib86","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.brainres.2005.07.061","article-title":"Neuroprotective effects of topiramate after hypoxia\u2013ischemia in newborn piglets","volume":"1058","author":"Schubert","year":"2005","journal-title":"Brain Res"},{"key":"10.1016\/j.siny.2013.04.005_bib87","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.yebeh.2005.03.001","article-title":"Effect of topiramate on cognitive function and activity level following neonatal seizures","volume":"6","author":"Zhao","year":"2005","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.siny.2013.04.005_bib88","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0006-8993(98)00410-7","article-title":"Neuroprotection by delayed administration of topiramate in a rat model of middle cerebral artery embolization","volume":"804","author":"Yang","year":"1998","journal-title":"Brain Res"},{"key":"10.1016\/j.siny.2013.04.005_bib89","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0304-3940(00)00847-8","article-title":"Protective effect of topiramate against hippocampal neuronal damage after global ischemia in the gerbils","volume":"281","author":"Lee","year":"2000","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.siny.2013.04.005_bib90","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1016\/S0024-3205(01)01306-6","article-title":"Topiramate as a neuroprotectant in a rat model of global ischemia-induced neurodegeneration","volume":"69","author":"Edmonds","year":"2001","journal-title":"Life Sci"},{"key":"10.1016\/j.siny.2013.04.005_bib91","doi-asserted-by":"crossref","first-page":"4412","DOI":"10.1523\/JNEUROSCI.0477-04.2004","article-title":"Glutamate receptor-mediated oligodendrocyte toxicity in periventricular leukomalacia: a protective role for topiramate","volume":"24","author":"Follett","year":"2004","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.siny.2013.04.005_bib92","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1111\/j.1471-4159.2005.03259.x","article-title":"Topiramate reduces AMPA-induced Ca(2+) transients and inhibits GluR1 subunit phosphorylation in astrocytes from primary cultures","volume":"94","author":"Angehagen","year":"2005","journal-title":"J\u00a0Neurochem"},{"key":"10.1016\/j.siny.2013.04.005_bib93","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0304-3940(97)00543-0","article-title":"Topiramate attenuates voltage-gated sodium currents in rat cerebellar granule cells","volume":"231","author":"Zona","year":"1997","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.siny.2013.04.005_bib94","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1161\/01.STR.0000217303.22856.38","article-title":"Multiple mechanisms underlying the neuroprotective effects of antiepileptic drugs against in\u00a0vitro ischemia","volume":"37","author":"Costa","year":"2006","journal-title":"Stroke"},{"key":"10.1016\/j.siny.2013.04.005_bib95","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.expneurol.2004.01.025","article-title":"Therapeutic doses of topiramate are not toxic to the developing rat brain","volume":"187","author":"Glier","year":"2004","journal-title":"Exp Neurol"},{"key":"10.1016\/j.siny.2013.04.005_bib96","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1111\/j.0013-9580.2004.65503.x","article-title":"Topiramate pharmacokinetics in children with epilepsy aged from 6 months to 4 years","volume":"45","author":"Mikaeloff","year":"2004","journal-title":"Epilepsia"},{"key":"10.1016\/j.siny.2013.04.005_bib97","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/epi.12019","article-title":"Pharmacokinetics and safety of adjunctive topiramate in infants (1\u201324 months) with refractory partial-onset seizures: a randomized, multicenter, open-label phase 1 study","volume":"54","author":"Manitpisitkul","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.siny.2013.04.005_bib98","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1111\/j.1528-1167.2009.02302.x","article-title":"Topiramate concentrations in neonates treated with prolonged whole body hypothermia for hypoxic ischemic encephalopathy","volume":"50","author":"Filippi","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.siny.2013.04.005_bib99","article-title":"Pharmacokinetics and safety of oral and intravenous topiramate in adult volunteers","author":"Kriel","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.siny.2013.04.005_bib100","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1177\/08830738050200080601","article-title":"Efficacy and tolerability of topiramate in children younger than 2 years old","volume":"20","author":"Valencia","year":"2005","journal-title":"J\u00a0Child Neurol"},{"key":"10.1016\/j.siny.2013.04.005_bib101","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S1059-1311(03)00183-3","article-title":"Topiramate efficacy in an infant with partial seizures refractory to conventional antiepileptic drugs","volume":"13","author":"Veggiotti","year":"2004","journal-title":"Seizure"},{"key":"10.1016\/j.siny.2013.04.005_bib102","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.pediatrneurol.2012.02.028","article-title":"Adaptive behaviour outcomes in infants treated with adjunctive topiramate","volume":"46","author":"Ness","year":"2012","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.siny.2013.04.005_bib103","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.jpeds.2010.04.019","article-title":"Oral topiramate in neonates with hypoxic ischemic encephalopathy treated with hypothermia: a safety study","volume":"157","author":"Filippi","year":"2010","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.siny.2013.04.005_bib104","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1046\/j.1528-1157.2003.27402.x","article-title":"The effects of adjunctive topiramate on cognitive function in patients with epilepsy","volume":"44","author":"Lee","year":"2003","journal-title":"Epilepsia"},{"key":"10.1016\/j.siny.2013.04.005_bib105","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.yebeh.2012.02.022","article-title":"Topiramate and its effect on fMRI of language in patients with right or left temporal lobe epilepsy","volume":"24","author":"Szaflarski","year":"2012","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.siny.2013.04.005_bib106","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.1468-1331.2012.03814.x","article-title":"Impaired verbal fluency under topiramate \u2013 evidence for synergistic negative effects of epilepsy, topiramate, and polytherapy","volume":"20","author":"Witt","year":"2013","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.siny.2013.04.005_bib107","doi-asserted-by":"crossref","DOI":"10.1016\/j.eplepsyres.2012.12.007","article-title":"The effect of topiramate on cognitive fMRI","author":"Yasuda","year":"2013","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.siny.2013.04.005_bib108","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.reprotox.2012.05.038","article-title":"Preliminary findings of the developmental effects of in utero exposure to topiramate","volume":"34","author":"Rihtman","year":"2012","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.siny.2013.04.005_bib109","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1177\/0883073811406982","article-title":"Long-term open-label study of adjunctive topiramate in infants with refractory partial-onset seizures","volume":"26","author":"Puri","year":"2011","journal-title":"J\u00a0Child Neurol"},{"key":"10.1016\/j.siny.2013.04.005_bib110","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1177\/0883073807300535","article-title":"Topiramate in children with west syndrome: a retrospective multicenter evaluation of 100 patients","volume":"22","author":"Korinthenberg","year":"2007","journal-title":"J\u00a0Child Neurol"},{"key":"10.1016\/j.siny.2013.04.005_bib111","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/WNF.0b013e3180986d43","article-title":"Evaluation of open-label topiramate as primary or adjunctive therapy in infantile spasms","volume":"31","author":"Zou","year":"2008","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.siny.2013.04.005_bib112","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.eplepsyres.2010.12.002","article-title":"A\u00a0prospective study on the treatment of infantile spasms with first-line topiramate followed by low-dose ACTH","volume":"93","author":"Zhu","year":"2011","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.siny.2013.04.005_bib113","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1046\/j.1528-1157.2003.11803.x","article-title":"Efficacy of topiramate in children with refractory status epilepticus","volume":"44","author":"Kahriman","year":"2003","journal-title":"Epilepsia"},{"key":"10.1016\/j.siny.2013.04.005_bib114","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1111\/j.1528-1167.2006.00564.x","article-title":"Topiramate loading for refractory status epilepticus in children","volume":"47","author":"Perry","year":"2006","journal-title":"Epilepsia"},{"key":"10.1016\/j.siny.2013.04.005_bib115","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1212\/WNL.0b013e3181d1cd4c","article-title":"Randomized trial of adjunctive topiramate therapy in infants with refractory partial seizures","volume":"74","author":"Novotny","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.siny.2013.04.005_bib116","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.pediatrneurol.2011.01.006","article-title":"Topiramate for the treatment of neonatal seizures","volume":"44","author":"Glass","year":"2011","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.siny.2013.04.005_bib117","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/1471-2431-12-144","article-title":"Safety and efficacy of topiramate in neonates with hypoxic ischemic encephalopathy treated with hypothermia (NeoNATI)","volume":"12","author":"Filippi","year":"2012","journal-title":"BMC Pediatr"},{"key":"10.1016\/j.siny.2013.04.005_bib118","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jpeds.2008.01.041","article-title":"Improving the treatment of neonatal seizures: national Institute of Neurological Disorders and Stroke workshop report","volume":"153","author":"Silverstein","year":"2008","journal-title":"J\u00a0Pediatr"}],"container-title":["Seminars in Fetal and Neonatal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1744165X13000279?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1744165X13000279?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T11:07:29Z","timestamp":1645096049000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1744165X13000279"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":118,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["S1744165X13000279"],"URL":"https:\/\/doi.org\/10.1016\/j.siny.2013.04.005","relation":{},"ISSN":["1744-165X"],"issn-type":[{"value":"1744-165X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Newly emerging therapies for neonatal seizures","name":"articletitle","label":"Article Title"},{"value":"Seminars in Fetal and Neonatal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.siny.2013.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}